Hurricane Helene delays Spectral Medical’s confirmatory trial enrolment
Spectral aims to finalise enrolment in early 2025 for its septic shock treatment Toraymyxin.
Therapy Area
OncoResponse reports data from Phase I solid tumour treatment trial
AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial
Bavarian Nordic’s mpox vaccine to be trialled in pregnant women and infants
Castle boasts melanoma test’s capacity to reduce unnecessary testing
Penumbra reveals positive data for algorithm-assisted thrombectomy tech
Intra-Cellular bolsters Caplyta data with another Phase III win
Abbott touts long-term efficacy for dissolvable Esprit BTK stent
